KMTS vs TROW · rev $95.1M vs P/E 12, rev $3.76B
Kestra Medical Technologies, Ltd. Common Stock (KMTS) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
KMTS currently screens at market cap $1.24B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the KMTS and TROW stock pages for the full models.
Not investment advice.